athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services and mobile applications for healthcare providers nationwide, today announced the acquisition of Filament Labs, Inc., d/b/a Patient IO (“Patient IO”), an Austin-based care coordination platform used by providers to engage patients and caregivers outside the four walls of the clinic.
Everbridge, Inc. today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be sold and the price range for the proposed offering have not yet been determined.
As per SEC filings, Sidekicks in Cambridge has raised $7.1M in funding. Sidekicks is a mission-driven, technology-based startup. The company's mobile virtual companion, Sidekicks, helps parents connect with kids with autism using their strong affinities...READ MORE
As per SEC filings, Immedia Semiconductor raised $11.9M in funding. Investors include Flybridge Capital Partnres. Immedia Semiconductor is the maker of Blink, a wireless home security & HD video monitoring system...READ MORE
Drizly, the technology company transforming the way alcohol is shopped, sold and shared online, today announced $15 million in Series B financing led by Polaris Partners with participation from existing investors. The new funding brings total investment in Drizly to $32.8 million and will be used to further drive the company’s rapid expansion and brand awareness, both in the U.S. and internationally.
As reported by Yahoo! Finance:
Andrew Miller thinks there’s a big mistake that major sports media properties are making these days: They’re all giving social platforms like Facebook and Twitter their best content for free. “They’re getting their lunch eaten,” he says, by letting top writers put most of their hottest content—analysis, opinions and breaking news scoops—into tweets that don’t bring any money to the employer.
Imprivata® (NYSE: IMPR), the healthcare IT security company, announced that it has entered into a definitive agreement to be acquired by an affiliate of Thoma Bravo, LLC, a leading private equity investment firm. Under the terms of the agreement, shareholders of record will receive $19.25 in cash per share of Imprivata common stock, which represents a 33% premium to Imprivata’s last closing stock price of $14.50. The value of the transaction is approximately $544 million.